Delivery Order SPE2DB22D3501-SPE2DB24FVE09
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $3.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,576.66 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, which has an ultimate completion date of March 21, 2024, is for the supply of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,747.18 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading pharmaceutical sourcing and distribution company. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through March 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $3,077.83 contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a specialty medication. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,231.73 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor. The IDC serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a potential value of $78,029.88. The contract has a completion date of March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,666.54 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NURTEC ODT 75 MG TABLET 8S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,837.61 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription pharmaceutical product, with a period of performance through March 18, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract valued at $7,259.23 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a specialty pharmaceutical product, with a period of performance through March 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,700.50 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide NURTEC ODT 75 MG TABLET 8S pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $9,199.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract, with a completion date of August 23, 2024, is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVE09Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $3,334.90 and an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to provide pharmaceuticals and medical supplies to military treatment facilities. The contract does not have a set-aside designation.
Generated 7/5/24, 9:16 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 4/5/24 |